Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 21-28 of 28

Page
per page
  1. Luteinizing hormone releasing hormone human acetate salt (LHRH)
    A1147 Luteinizing hormone releasing hormone human acetate salt (LHRH)
    Target: MMP
    Summary: acitivator of MMP-2 and MMP-9, selective
      ≥118.2 mg/mL
  2. (Z)-4-Hydroxytamoxifen
    B5421 (Z)-4-Hydroxytamoxifen
    Target: Estrogen and Related Receptors
    Summary: ER modulator, potent and selective
      ≥38.8 mg/mL
  3. G-1
    B5455 G-1
     4 Citation
    Target: GPR30
    Summary: GPR30 agonist, potent and selective
      ≥41.2 mg/mL
  4. G-15
    B5469 G-15
     3 Citation
    Target: GPR30
    Summary: GPER receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥37 mg/mL
  5. DPDPE
    B5111 DPDPE
    Summary: Prototypical selective δ-opioid receptor agonist peptide
      Soluble to 1 mg/mL
  6. nor-Binaltorphimine dihydrochloride
    B6269 nor-Binaltorphimine dihydrochloride
    Summary: κ-opioid receptor antagonist
      <18.37 mg/mL
  7. Naltrindole hydrochloride
    B6429 Naltrindole hydrochloride
    Summary: δ opioid antagonist
      Soluble in DMSO
  8. DAMGO
    B6621 DAMGO
    Summary: μ opioid receptor agonist

Items 21-28 of 28

Page
per page